For conservative or long-term investors, the stock carries high risk and weak overall ratings:
: A buy signal was issued from a "pivot bottom" on April 17, 2026, and the stock carries positive signals from its 3-month MACD (Moving Average Convergence Divergence). The "Sell" Argument (Fundamental & Long-Term Risk)
: NDEV does not pay dividends, making it unattractive for income-focused investors. Financial Highlights (April 2026) 52-Week High Yahoo Finance 52-Week Low Barron's Market Cap $1.47 Million TradingView Net Income (Qtr) MarketWatch ndev buy or sell
: The stock is characterized by extreme price swings—up to 50.38% in a single day—which classifies it as a "high risk" investment.
: The stock gained 18.24% on April 24, 2026, rising to $0.0175 with increased volume, which is often viewed as a positive sign of price formation. For conservative or long-term investors, the stock carries
Are you interested in a of NDEV's moving averages, or should we look at comparable stocks in the cannabis insurance sector? Google's Finance Data
: Ratings from Tickeron highlight a Valuation Rating of 100 (where 100 is worst/significantly overvalued) and an SMR rating of 100 , indicating an unprofitable business model and weak sales. : The stock gained 18
: Both 1-week and 1-month technical ratings on platforms like TradingView signal a Sell or Strong Sell .